BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28625137)

  • 1. Chemokine Like Receptor-1 (CMKLR-1) Receptor: A Potential Therapeutic Target in Management of Chemerin Induced Type 2 Diabetes Mellitus and Cancer.
    Perumalsamy S; Aqilah Mohd Zin NA; Widodo RT; Wan Ahmad WA; Vethakkan SRDB; Huri HZ
    Curr Pharm Des; 2017; 23(25):3689-3698. PubMed ID: 28625137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trimethylamine N-oxide (TMAO) as a New Potential Therapeutic Target for Insulin Resistance and Cancer.
    Oellgaard J; Winther SA; Hansen TS; Rossing P; von Scholten BJ
    Curr Pharm Des; 2017; 23(25):3699-3712. PubMed ID: 28641532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemerin: a potential endocrine link between obesity and type 2 diabetes.
    Roman AA; Parlee SD; Sinal CJ
    Endocrine; 2012 Oct; 42(2):243-51. PubMed ID: 22610747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemerin exacerbates glucose intolerance in mouse models of obesity and diabetes.
    Ernst MC; Issa M; Goralski KB; Sinal CJ
    Endocrinology; 2010 May; 151(5):1998-2007. PubMed ID: 20228173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) as a Target for Concurrent Management of Diabetes and Obesity-Related Cancer.
    Wang Q; Imam MU; Yida Z; Wang F
    Curr Pharm Des; 2017; 23(25):3677-3688. PubMed ID: 28677503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of lifestyle modification on serum chemerin concentration and its association with insulin sensitivity in overweight and obese adults with type 2 diabetes.
    Kim SH; Lee SH; Ahn KY; Lee DH; Suh YJ; Cho SG; Choi YJ; Lee DH; Lee SY; Hong SB; Kim YS; Jeon JY; Nam M
    Clin Endocrinol (Oxf); 2014 Jun; 80(6):825-33. PubMed ID: 23682797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated plasma levels of chemerin in newly diagnosed type 2 diabetes mellitus with hypertension.
    Yang M; Yang G; Dong J; Liu Y; Zong H; Liu H; Boden G; Li L
    J Investig Med; 2010 Oct; 58(7):883-6. PubMed ID: 20601896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progranulin and chemerin plasma level in obese patients with type 2 diabetes treated with a long-acting insulin analogue and premixed insulin analogue.
    Waluga-Kozlowska E; Kuznik-Trocha K; Komosinska-Vassev K; Olczyk P; Jura-Poltorak A; Winsz-Szczotka K; Telega A; Ivanova D; Strzoda W; Zimmermann A; Janik M; Olczyk K; Waluga M
    J Physiol Pharmacol; 2021 Dec; 72(6):. PubMed ID: 35377341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress in the contrary effects of glucagon-like peptide-1 and chemerin on obesity development.
    Zhang Q; Ye J; Wang X
    Exp Biol Med (Maywood); 2023 Nov; 248(22):2020-2029. PubMed ID: 38058030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemerin as an Inducer of β Cell Proliferation Mediates Mitochondrial Homeostasis and Promotes β Cell Mass Expansion.
    Li M; Zhang R; Ge Q; Yue L; Ma D; Khattab F; Xie W; Cui Y; Gilon P; Zhao X; Li X; Cheng R
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diabetes and cancer risk: oncologic considerations].
    Rosta A
    Orv Hetil; 2011 Jul; 152(29):1144-55. PubMed ID: 21712179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G protein-coupled receptors as targets for anti-diabetic therapeutics.
    Oh DY; Olefsky JM
    Nat Rev Drug Discov; 2016 Mar; 15(3):161-72. PubMed ID: 26822831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent Advances on the Role of microRNAs in both Insulin Resistance and Cancer.
    Vivacqua A; De Marco P; Belfiore A; Maggiolini M
    Curr Pharm Des; 2017; 23(25):3658-3666. PubMed ID: 28641547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin: taking away the candy for cancer?
    Jalving M; Gietema JA; Lefrandt JD; de Jong S; Reyners AK; Gans RO; de Vries EG
    Eur J Cancer; 2010 Sep; 46(13):2369-80. PubMed ID: 20656475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of Chemokines and Chemokine Receptors in Obesity-Associated Insulin Resistance and Nonalcoholic Fatty Liver Disease.
    Xu L; Kitade H; Ni Y; Ota T
    Biomolecules; 2015 Jul; 5(3):1563-79. PubMed ID: 26197341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The combined effect of metformin and L-cysteine on inflammation, oxidative stress and insulin resistance in streptozotocin-induced type 2 diabetes in rats.
    Salman ZK; Refaat R; Selima E; El Sarha A; Ismail MA
    Eur J Pharmacol; 2013 Aug; 714(1-3):448-55. PubMed ID: 23845213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards an integrative approach to understanding the role of chemerin in human health and disease.
    Rourke JL; Dranse HJ; Sinal CJ
    Obes Rev; 2013 Mar; 14(3):245-62. PubMed ID: 23216632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. More Than an Adipokine: The Complex Roles of Chemerin Signaling in Cancer.
    Goralski KB; Jackson AE; McKeown BT; Sinal CJ
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Cardioprotective Effect of L-Carnitine on Obese Diabetic Mice: Regulation of Chemerin and CMKLRI Expression in Heart and Adipose Tissues.
    Amiri R; Tabandeh MR; Hosseini SA
    Arq Bras Cardiol; 2021 Oct; 117(4):715-725. PubMed ID: 34709299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of chemerin in the control of glucose homeostasis.
    Léniz A; González M; Besné I; Carr-Ugarte H; Gómez-García I; Portillo MP
    Mol Cell Endocrinol; 2022 Feb; 541():111504. PubMed ID: 34763009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.